Back to search

United States· US:0404-9966_3ca78482-bb78-4238-88d7-f39e4164aacd

Verapamil Hydrochloride

A verapamil product containing verapamil hydrochloride, registered in United States by Henry Schein, Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC C08DA01

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedVerapamil HydrochlorideATCC08DA01REGISTER NO.US:0404-9966_3ca78482…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Verapamil is registered in 17 of 19 countries.

Countries holding a registration under ATC C08DA01 (verapamil), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Verapamil · ATC C08DA01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of verapamil costs, country by country.

Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.21 in France to $0.95 in Switzerland — a ×4.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Verapamil · price per daily dose (0.24 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.95
  • IT Italy$0.31
  • FR France$0.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
VERAPAMIL HYDROCHLORIDE
Manufacturer
Henry Schein, Inc.
Country
United States (US)
ATC code
C08DA01
ATC class
Verapamil
Defined daily dose
0.24 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    0404-9966-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

467 interactions on record for verapamil.

Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Verapamil · interactions on record

467 records

  • 52 severe
  • 223 moderate
  • 23 minor
  • 143 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe
  • LoperamideA07DA03severe

26 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Verapamil in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All verapamil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Isoptin, Isoptin Retard
  • Belgium · Fibrocard, Isoptine
  • Bulgaria · Верапамил Софарма, Верапамил Чайкафарма
  • Cyprus · Akilen, Caveril
  • Czechia · Isoptin, Isoptin Sr
  • Germany · Isoptin, Isoptin Khk Retard
  • Denmark · Isoptin Retard, Veraloc
  • Estonia · Isoptin Retard, Verapamil Ratiopharm
  • Spain · Manidón, Manidón Hta
  • Finland · Isoptin Retard, Veramacor
  • France · Isoptine, Isoptine L.P.
  • United Kingdom (Northern Ireland) · Half Securon Sr, Securon Sr
  • Greece · Isoptin
  • Croatia · Isoptin, Isoptin Rr
  • Hungary · Chinopamil, Isoptin
  • Ireland · Isoptin, Isoptin Sr
  • Iceland · Isoptin Retard, Veraloc Retard
  • Italy · Isoptin, Verapamil Doc Generici
  • Lithuania · Isoptin Retard, Verapamil Ratiopharm
  • Luxembourg · Isoptin, Isoptin Khk Retard
  • Latvia · Isoptin Retard
  • Malta · Caveril, Isoptin
  • Netherlands · Isoptin Sr, Verapamil Hcl Cf
  • Norway · Isoptin, Isoptin Retard
  • Poland · Isoptin 40, Isoptin 80
  • Portugal · Isoptin, Isoptin Dc
  • Romania · Cordamil, Isoptin Rr
  • Sweden · Isoptin, Isoptin Retard
  • Slovakia · Isoptin, Isoptin Ichs Retard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee7626b8-4e89-4e5e-a28f-ca3d4d64d9e3
GET /v1/drugs/ee7626b8-4e89-4e5e-a28f-ca3d4d64d9e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "2.5",
  "substance": "VERAPAMIL HYDROCHLORIDE",
  "productndc": "0404-9966",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA211015",
  "marketing_category": "ANDA"
}

See everything about verapamil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.